Literature DB >> 16218379

[Epidemiology of headache].

Hirohisa Okuma1, Yasuhisa Kitagawa.   

Abstract

We discuss here the epidemiology of chronic headache. Headache is a widespread and costly public health problem. Few people do not experience headache: in men, the lifetime prevalence for headache of any kind is 93 %, and for women it is up to 99%. Approximately 8.4 million people in Japan suffer from migraine, and 22 million have tension-type headache. Despite the painful, costly, and disabling impact of headache, many patients with headache do not seek medical advice. It is important to recognize the incidence of various kinds of chronic headache, and to diagnose and treat them correctly. In this article, we review the incidence, precipitating factors, regional prevalence, and age dependence of the incidence of each type of chronic headache.

Entities:  

Mesh:

Year:  2005        PMID: 16218379

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

1.  Preliminary development of a deep learning-based automated primary headache diagnosis model using Japanese natural language processing of medical questionnaire.

Authors:  Masahito Katsuki; Norio Narita; Yasuhiko Matsumori; Naoya Ishida; Ohmi Watanabe; Siqi Cai; Teiji Tominaga
Journal:  Surg Neurol Int       Date:  2020-12-29

2.  Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study.

Authors:  Masahito Katsuki; Junko Kawahara; Yasuhiko Matsumori; Chinami Yamagishi; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Miyako Otake; Takashi Ikeda; Fuminori Yamagishi
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

3.  Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study.

Authors:  Masahito Katsuki; Chinami Yamagishi; Yasuhiko Matsumori; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Takashi Ikeda; Fuminori Yamagishi
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.830

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.